Ipsen Sa · EURONEXT:IPN
Ipsen Sa — Fact Sheet (April 2025)
1 slide from Ipsen Sa's fact sheet, April 2025
Slide 1: Q1 2025 Highlights
Q1 2025 HIGHLIGHTS “Ipsen has delivered a strong start to 2025, building further momentum in the transformation of our company” David Loew - Chief Executive Officer TOTAL SALES GEOGRAPHIC BREAKDOWN North America 36% Q1 PIPELINE PROGRESS of total sales Regulatory filing accepted by EMA2 – tovorafenib